<- Go Home
Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally.
Market Cap
$1.6B
Volume
44.8K
Cash and Equivalents
$362.9M
EBITDA
$38.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$305.0M
Profit Margin
48.47%
52 Week High
$45.76
52 Week Low
$32.67
Dividend
N/A
Price / Book Value
0.90
Price / Earnings
29.98
Price / Tangible Book Value
0.91
Enterprise Value
$277.7M
Enterprise Value / EBITDA
7.23
Operating Income
$7.3M
Return on Equity
3.06%
Return on Assets
0.21
Cash and Short Term Investments
$879.4M
Debt
N/A
Equity
$1.8B
Revenue
$629.2M
Unlevered FCF
$21.0M
Sector
Pharmaceuticals
Category
N/A